» Articles » PMID: 18521710

Nuclear Localization of Myomesin-1: Possible Functions

Overview
Specialties Cell Biology
Physiology
Date 2008 Jun 4
PMID 18521710
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Myomesin-I (also known as Skelemin) is a approximately 185 kDa protein, which is highly expressed in striated muscle. It contains the prototypic class-I (type-III fibronectin) and class-II (C2-immunoglobulin) motifs. Previous studies have shown the presence of Myomesin-I at the M-line of the sarcomere, where it is thought to interact with thick filament constituents. As reported previously, Myomesin-I was localized to the M-line in the adult cardiac myocytes (adult-myocytes). However, we found that Myomesin-I was also present exclusively in the nucleus of myocytes isolated from new born pups (neonatal-myocytes). In addition, the ectopically expressed Myomesin-I was primarily targeted to the nucleus, similar to the neonatal myocytes. Further investigations revealed that the nuclear-targeting signals were present within the N-terminal 256 residues. A strong consensus sequence for sumoylation is present within the N-terminal 256 residues and is implicated in the shuttling of Myomesin-I between nucleus and cytoplasm. Gene array analysis showed that the presence of Myomesin-I in the nucleus led to the differential expression of more than 42 genes. These studies show a novel and previously unknown localization and function for Myomesin-I.

Citing Articles

Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study.

Sakarin S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanit S Front Vet Sci. 2024; 11:1327453.

PMID: 38596466 PMC: 11002142. DOI: 10.3389/fvets.2024.1327453.


Pathogenesis of Cardiomyopathy Caused by Variants in , an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere.

Agarwal R, Wakimoto H, Paulo J, Zhang Q, Reichart D, Toepfer C Circulation. 2022; 146(22):1674-1693.

PMID: 36321451 PMC: 9698156. DOI: 10.1161/CIRCULATIONAHA.122.059688.


Knockout of MYOM1 in human cardiomyocytes leads to myocardial atrophy via impairing calcium homeostasis.

Hang C, Song Y, Li Y, Zhang S, Chang Y, Bai R J Cell Mol Med. 2021; 25(3):1661-1676.

PMID: 33452765 PMC: 7875908. DOI: 10.1111/jcmm.16268.


Myomesin is part of an integrity pathway that responds to sarcomere damage and disease.

Prill K, Carlisle C, Stannard M, Windsor Reid P, Pilgrim D PLoS One. 2019; 14(10):e0224206.

PMID: 31644553 PMC: 6808450. DOI: 10.1371/journal.pone.0224206.


Thick Filament Protein Network, Functions, and Disease Association.

Wang L, Geist J, Grogan A, Hu L, Kontrogianni-Konstantopoulos A Compr Physiol. 2018; 8(2):631-709.

PMID: 29687901 PMC: 6404781. DOI: 10.1002/cphy.c170023.


References
1.
Lange S, Himmel M, Auerbach D, Agarkova I, Hayess K, Furst D . Dimerisation of myomesin: implications for the structure of the sarcomeric M-band. J Mol Biol. 2004; 345(2):289-98. DOI: 10.1016/j.jmb.2004.10.040. View

2.
Kim K, Baek S, Chung C . Versatile protein tag, SUMO: its enzymology and biological function. J Cell Physiol. 2002; 191(3):257-68. DOI: 10.1002/jcp.10100. View

3.
Lin X, Sun B, Liang M, Liang Y, Gast A, Hildebrand J . Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell. 2003; 11(5):1389-96. DOI: 10.1016/s1097-2765(03)00175-8. View

4.
Belevych A, Sims C, Harvey R . ACh-induced rebound stimulation of L-type Ca(2+) current in guinea-pig ventricular myocytes, mediated by Gbetagamma-dependent activation of adenylyl cyclase. J Physiol. 2001; 536(Pt 3):677-92. PMC: 2278900. DOI: 10.1111/j.1469-7793.2001.00677.x. View

5.
Verger A, Perdomo J, Crossley M . Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 2003; 4(2):137-42. PMC: 1315836. DOI: 10.1038/sj.embor.embor738. View